Typhoid Vi polysaccharide vaccine(Changchun Longevity)

伤寒Vi多糖疫苗（长春长生）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTyphoid Vi polysaccharide vaccine(Changchun Longevity)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesChangchun Longevity Biological Technology Limited Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangchun Longevity Biological Technology Limited Liability Company
Active IndicationsN/A
Inactive IndicationsTyphoid Fever

Other Information

ATC CodeN/A
Related LinksN/A